Medically reviewed by Drugs.com. Last updated on Aug 30, 2019.
Applies to the following strengths: 175 mcg/3 mL
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Chronic Obstructive Pulmonary Disease - Maintenance
One 175 mcg vial once a day via a nebulizer with a mouthpiece
Renal Dose Adjustments
No adjustment recommended.
-Monitor severe renal impairment patients for systemic antimuscarinic adverse effects.
Liver Dose Adjustments
Not recommended with any degree of hepatic impairment.
-In moderate hepatic impairment, systemic exposure to the drug is unchanged, but exposure to the active metabolite is increased.
-Safety has not been evaluated in COPD patients with any level of hepatic impairment.
-Hypersensitivity to any of the ingredients
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Data not available
-For inhalation via a standard jet nebulizer connected to an air compressor; safety and efficacy have not been established with non-compressor based nebulizer systems.
-Safety and efficacy have been established with the PARLIC(R) Sprint nebulizer with mouthpiece and the PARI Trek(R) compressor.
-Only remove the unit dose vial from the pouch immediately before administration.
-Store in protective foil pouch.
-Store at room temperature; protect from direct sunlight and excessive heat
More about revefenacin
- Side Effects
- During Pregnancy
- Drug Interactions
- En Español
- Drug class: anticholinergic bronchodilators
Other brands: Yupelri